| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2008 | EP1147106B1 Process for the preparation of alkyl mercapto methyl ergoline derivatives |
| 02/13/2008 | EP1140022B1 Method of administering a compound to multi-drug resistant cells |
| 02/13/2008 | EP1044189B1 Aryl fused azapolycyclic compounds |
| 02/13/2008 | EP0909132B2 Dietetic baby food formula containing conjugated linoleic acids |
| 02/13/2008 | EP0906335B1 Ebv type b ctl epitopes |
| 02/13/2008 | EP0833652B1 Novel kappa receptor selective opioid peptides |
| 02/13/2008 | EP0758244B2 Controlled-release dosage forms of azithromycin |
| 02/13/2008 | CN101124322A RNAi inhibition of serum amyloid A for treatment of glaucoma |
| 02/13/2008 | CN101124232A 烟碱乙酰胆碱受体的配体 Nicotinic acetylcholine receptor ligands |
| 02/13/2008 | CN101124231A Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |
| 02/13/2008 | CN101124229A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 02/13/2008 | CN101124228A Pyrazolopyrimidine compounds as antitumor agents |
| 02/13/2008 | CN101124227A Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity |
| 02/13/2008 | CN101124226A 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 02/13/2008 | CN101124225A Metabolites of certain [1,4]diazepino[6,7,1-IJ]quinoline derivatives and methods of preparation and use thereof |
| 02/13/2008 | CN101124224A Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 02/13/2008 | CN101124223A Pyrido-pyrimidine derivatives, preparation thereof, therapeutic use thereof |
| 02/13/2008 | CN101124222A Tetrahydroquinoline analogues as muscarinic agonists |
| 02/13/2008 | CN101124220A 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents |
| 02/13/2008 | CN101124219A Novel farnesyl protein transferase inhibitors as antitumor agents |
| 02/13/2008 | CN101124217A CGRP receptor antagonists |
| 02/13/2008 | CN101124216A Heterocyclic MCHr1 antagonists and their use in therapy |
| 02/13/2008 | CN101124215A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders |
| 02/13/2008 | CN101124213A Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors |
| 02/13/2008 | CN101124212A Chroman derivatives and their use as 5-HT receptor ligands |
| 02/13/2008 | CN101124211A Antibiotic FKI-1778 and its production method |
| 02/13/2008 | CN101124210A Tetralin and indane derivatives and uses thereof |
| 02/13/2008 | CN101124207A Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| 02/13/2008 | CN101124206A 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
| 02/13/2008 | CN101124205A Substituted aminopyridines and uses thereof |
| 02/13/2008 | CN101124204A Amorphous lercanidipine hydrochloride |
| 02/13/2008 | CN101124203A Chemical compounds |
| 02/13/2008 | CN101124200A Methods and fluorinated compositions for treating amyloid-related diseases |
| 02/13/2008 | CN101124198A Medicine compound and composition |
| 02/13/2008 | CN101124197A Substantially pure tolterodine tartrate and process for preparing thereof |
| 02/13/2008 | CN101124195A Purification process |
| 02/13/2008 | CN101123993A Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/13/2008 | CN101123986A Glucocerebroside treatment of disease |
| 02/13/2008 | CN101123985A Therapeutic agent for constipation |
| 02/13/2008 | CN101123973A 4000 to 10000 dalton oligodeoxyribonucleotides for treating tumor |
| 02/13/2008 | CN101123972A Methods for protein production |
| 02/13/2008 | CN101123971A Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 02/13/2008 | CN101123970A Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 02/13/2008 | CN101123969A Cardiovascular compositions |
| 02/13/2008 | CN101123968A Methods for treating mast cell disorders |
| 02/13/2008 | CN101123967A Transdermal administration of phycotoxins |
| 02/13/2008 | CN101123966A Combination therapy comprising the use of ET-743 and doxorubicin for treating cancer |
| 02/13/2008 | CN101123965A Methylphenidate derivatives and uses of methylphenidate derivatives |
| 02/13/2008 | CN101123964A G-protein coupled receptor(GPR116) agonists and use thereof for treating obesity and diabetes |
| 02/13/2008 | CN101123963A Sabcomeline alone or combined with a mood stabilising or antimanic agent to treat bipolar disorders |
| 02/13/2008 | CN101123962A 可诱导一氧化氮合成酶二聚化的抑制剂 Inducible nitric oxide synthase dimerization inhibitor |
| 02/13/2008 | CN101123961A Fast release dosage forms for antibiotics |
| 02/13/2008 | CN101123960A Use of staurosporine derivatives for the treatment of multiple myeloma |
| 02/13/2008 | CN101123959A Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 02/13/2008 | CN101123958A Combinational radiotherapy and chemotherapy compositions and methods |
| 02/13/2008 | CN101123957A Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
| 02/13/2008 | CN101123956A Use of PPAR agonists to treat ruminants |
| 02/13/2008 | CN101123955A 5HT2C receptor modulator compositions and methods of use |
| 02/13/2008 | CN101123954A Anti-tumor agent |
| 02/13/2008 | CN101123953A Method for transformation of conventional and commercially important polymers into durable and rechargeable antimicrobial polymeric materials |
| 02/13/2008 | CN101123951A Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| 02/13/2008 | CN101123950A Pharmaceutical formulation containing an LTB4 antagonist, method for the production thereof, and use thereof |
| 02/13/2008 | CN101123880A Anti-tumor compounds with angeloyl groups |
| 02/13/2008 | CN101121934A Multiple target points miRNA antisense nucleic acid technique |
| 02/13/2008 | CN101121750A Humanized anti-erbb2 antidbodies and treatment with anti-erbb2 antibodies |
| 02/13/2008 | CN101121743A Process for extracting anticancer product from natural plant |
| 02/13/2008 | CN101121742A Panaxadiol fatty acid esters derivatives, preparation method and application thereof in pharmacy |
| 02/13/2008 | CN101121740A Technique for preparing verbascoside with function of curing chronic glomerulonephritis in glutinous rehmannia leaf |
| 02/13/2008 | CN101121739A Hydrolysable tannin and application thereof |
| 02/13/2008 | CN101121738A 1,3-O-di-galloyl-6-O-(S)-decapetalous caesalpinia acyl-beta-D-glucopyranose and application thereof |
| 02/13/2008 | CN101121737A Novel hydrolysable tannin and application thereof |
| 02/13/2008 | CN101121711A Pyrazolcarbazone derivatives and application thereof |
| 02/13/2008 | CN101121706A Coumarin derivatives, preparation method and use thereof |
| 02/13/2008 | CN101121702A Phenoxy indanone derivatives containing alkylamino side-chain, preparation method and use thereof |
| 02/13/2008 | CN101121701A Five-membered rings 3-position single-substituted benzosultam derivatives and preparation method thereof |
| 02/13/2008 | CN101121698A Diarylmiazines derivatives, preparation method and use thereof |
| 02/13/2008 | CN101121696A Metal salt of pyritinol and hydrate of the same |
| 02/13/2008 | CN101121677A Agmatine sulfate dihydrate and medical use thereof |
| 02/13/2008 | CN101121674A Compound N-((2R,3S,E)-1,3-dihydroxy-17-methyloctadecyl-8-en-2-yl)acetamide |
| 02/13/2008 | CN101121672A Betaine phosphate and its producing method and applicaiton |
| 02/13/2008 | CN101121662A Chlorogenic acid ester derivative, preparation method and application thereof in pharmaceutical preparation |
| 02/13/2008 | CN101121519A Hollow silicon dioxide sub-micron sphere with inner core and its preparation method and use |
| 02/13/2008 | CN101121021A Humanized anti-ErbB2 antidbodies and treatment with anti-ErbB2 antibodies |
| 02/13/2008 | CN101121004A Medicine composition containing insulin intensifier and miglitol |
| 02/13/2008 | CN101120959A Application of guhong injection for treating lung cancer |
| 02/13/2008 | CN101120958A Medicinal preparation for treating liver cancer and leukemia and producing technology thereof |
| 02/13/2008 | CN101120957A Traditional Chinese medicine composition for treating respiratory system infection and preparation technology thereof |
| 02/13/2008 | CN101120954A Medicinal composition containing GTF active extract and its preparation technology |
| 02/13/2008 | CN101120951A Ovarian moisturing soft capsule and preparing process thereof |
| 02/13/2008 | CN101120949A Traditional Chinese medicine for treating haemorrhoids |
| 02/13/2008 | CN101120948A Compound composition with chemical protecting, cancer preventing and treating use |
| 02/13/2008 | CN101120947A Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 02/13/2008 | CN101120946A Medicine for treating alzheimer's disease |
| 02/13/2008 | CN101120945A Application of 8-arylamine-3H-imidazole [4, 5-g] quinazoline derivatives |
| 02/13/2008 | CN101120944A Composition containing inhibitor of thromboxane synthetase and nitrate esters medicine |
| 02/13/2008 | CN101120943A Medicinal composition for treating glioma, preparation method and preparation thereof |
| 02/13/2008 | CN101120942A Compound medicine preparation for treating cardiac and cerebral vascular diseases |
| 02/13/2008 | CN101120941A Methylcantharidimide injection and freeze-dried powder injection for treating tumor and preparation method thereof |
| 02/13/2008 | CN101120940A Application of tanshinone IIA sodium sulfonate as blood-brain barrier protecting agent in cerebral diseases |
| 02/13/2008 | CN101120939A Medicinal composition containing nitrate esters for treating ventricular hypertrophy or myocardial fibrosis |